26 University Of Louisville 230 East Broadway — Louisville, Kentucky

26 University Of Louisville 230 East Broadway is a clinical research site located in Louisville, Kentucky, United States 40402.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

26 University Of Louisville 230 East Broadway has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Disease.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 26 University Of Louisville 230 East Broadway?

26 University Of Louisville 230 East Broadway has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 26 University Of Louisville 230 East Broadway conducted?

26 University Of Louisville 230 East Broadway has 1 clinical trials on record. Their work covers Meningococcal Disease.

Is 26 University Of Louisville 230 East Broadway accredited by Crixeo Health?

26 University Of Louisville 230 East Broadway has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 26 University Of Louisville 230 East Broadway?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.